<DOC>
	<DOCNO>NCT00812188</DOCNO>
	<brief_summary>Compare UVA-1 phototherapy treatment topical steroid treatment subject morphea .</brief_summary>
	<brief_title>Treatment Study Comparing Medium High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05 % Cream Treatment Morphea .</brief_title>
	<detailed_description />
	<mesh_term>Scleroderma , Localized</mesh_term>
	<mesh_term>Fluocinonide</mesh_term>
	<criteria>Male female subject 18 year age old . Symmetric limit morphea . Known sensitivity fluocinonide 0.05 % cream . Clinical evidence superinfect skin . Immunocompromised state ( include previously document HIV ) . Generalized Scleroderma . Previous history skin cancer . NonEnglish speaking subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Morphea</keyword>
	<keyword>Plaque morphea</keyword>
	<keyword>Localized Scleroderma</keyword>
</DOC>